NORML

APRIL 14, 2020

According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report , the agency and its law enforcement partners confiscated an estimated four million marijuana plants in 2019 – up from 2.8 By contrast, marijuana-related marijuana arrests compiled by the DEA fell to 4,718 in 2019 – a decrease of 16 percent from 2018’s totals. It was the second-lowest number of arrests reported by the DEA in the past decade.

DEA 180

DEA Cultivation Programs Data 180

NORML

APRIL 8, 2020

As a result, the DEA has been encouraged for over a decade to expand the pool of federally licensed cannabis producers — a move that the agency has largely resisted. To date, however, the DEA has failed to either affirm or reject any of the more than 30 applications it has received. ON BACKGROUND: The DEA has consistently discouraged the scientific investigation of cannabis, particularly with respect to its therapeutic properties. *

DEA 183

DEA Cultivation Clinical Trials Access 183

NORML

JULY 16, 2019

According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 2.82 However, while the total number of DEA-seized plants fell in 2018, seizures of indoor cannabis plants nearly doubled – rising from 304,000 plants in 2017 to just under 600,000 in 2018. LAW ENFORCEMENT assets DEA eradication legalization seizures

DEA 166

DEA Data Retail Marijuana 166

NORML

MARCH 26, 2020

The DEA now estimates that, under the new rules, it may approve between three and 15 total applicants. ” He added, “Further, the DEA has an incredibly poor track record in this arena – having for years now promised to expedite and streamline this process, but failing to deliver. In 2016, the DEA publicly announced that it would, for the first time, begin accepting applications from private entities wishing to grow research-grade cannabis.

DEA 161

DEA Cultivation Extraction THC 161

NORML

AUGUST 26, 2019

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. According to the agency’s filing today in the Federal Register, the DEA “intends to promulgate regulations” to evaluate several dozen applications before it from private entities that wish to cultivate cannabis for FDA-approved research. FDA GOVERNMENT SCIENCE DEA medical research University of Mississippi

DEA 166

DEA Cultivation Compliance Compliance 166

Leafly

JUNE 8, 2020

The DEA's five-part test to determine 'currently accepted medical use' is flawed, say the plaintiffs. The post New lawsuit aims to force DEA to reschedule marijuana appeared first on Leafly. Politics cannabis research Controlled Substances Act DEA medical marijuana rescheduling research Schedule I

DEA 86

DEA Marijuana Cannabis 86

Leafly

MARCH 22, 2019

The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas.

DEA 88

DEA CBD 88

Cannabis Law Report

DECEMBER 3, 2020

The post DEA Asks Court To Overturn Cannabis Rescheduling Appeal first appeared on Cannabis Law Report. The U.S.

DEA 90

DEA Marijuana Cannabis Law 90

Leafly

AUGUST 26, 2019

Two days before a federal court deadline, the DEA says it will do what it said it would do three years ago. The post DEA Says It Will Finally Let Others Grow Research-Grade Cannabis appeared first on Leafly. Politics DEA research

DEA 84

DEA Cannabis 84

Cannabis Law Report

JULY 29, 2020

One could argue at the moment that some US Federal Agencies have employees on the books who could be accused via their behaviour of scamming … Read More. Breaking News

DEA 56

DEA 56

NORML

OCTOBER 21, 2019

Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications. However, most of those applications have been before DEA for several years, and the agency still has yet to provide any explicit timeline regarding when, if ever it intends to act on them.

DEA 101

DEA Cultivation Clinical Trials History 101

Cannabis Law Report

OCTOBER 27, 2020

A vague memory tells us that the DEA were looking for a contractor early 2019 ? The post DEA - We're Still Burnin' Weed first appeared on Cannabis Law Report. What happened to the last contractor. Marijuana Moment has … Read More.

DEA 56

DEA Law Marijuana Cannabis 56

NORML

JUNE 3, 2020

As first reported by Buzzfeed News , the federal Drug Enforcement Administration (DEA) is expanding its law enforcement powers so that it can better assist “to the maximum extent possible in the federal law enforcement response” to the wave of ongoing, nationwide protests that have followed the killing of George Floyd by a member of the Minneapolis police. The DEA possesses the power to strictly enforce these violations of law.

DEA 197

DEA Law Advocacy Events 197

NORML

AUGUST 2, 2019

” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. Read NORML’s new op-ed, “Three years ago the DEA said they would remove roadblocks to cannabis research — they still haven’t, here.). “While most states recognize that cannabis has medical value, the DEA says otherwise, pointing to the absence of clinical research.

Cultivation 175

Cultivation DEA Policy Safety 175

HarrisBricken

DECEMBER 18, 2020

On December 3, 2020, MAPS (the Multidisciplinary Association for Psychedelic Studies) issued a press release regarding a lawsuit filed against the DEA and the Attorney General to “compel issuance of licenses to manufacture marijuana for clinical trials and potential FDA approval.”

Research and Development 108

Research and Development DEA Clinical Trials Pharmaceutical 108

Canna Law Blog

JUNE 17, 2020

Buzzfeed News first reported that the Department of Justice expanded the Drug Enforcement Administration’s (DEA) jurisdiction in response to these protests. According to a DEA memorandum , the agency requested to expand its jurisdiction beyond federal drug laws to include the enforcement of “any federal crime committed as a result of protests over the death of George Floyd.” The DEA should be defunded or, better yet, disbanded, as we suggested way back in 2015.

DEA 63

DEA Policy History Programs 63

Americans for Safe Access

JUNE 2, 2020

On March 23, DEA published a proposed rulemaking —“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes. In the comments, we suggest to federal legislators and the DEA that a new agency be established that has no history in prosecution of the activities of which the DEA seeks to become the sole enforcer.

DEA 164

DEA Clinical Trials History Cultivation 164

WeedAdvisor

JULY 4, 2019

Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. However, the DEA does not keep its staff employed without drugs to seize, with marijuana being an easy target. It could be argued that the DEA is hesitant for the sake of public safety. Here, DEA can act with little expenditure of resources.”.

Research and Development 87

Research and Development DEA Clinical Trials Cultivation 87

Leafly

AUGUST 19, 2019

The post Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis? Science & Tech DEA nida researchYes, it was. So why has the agency delayed applications? Sue Sisley demands an answer, and the courts agree with her. appeared first on Leafly.

DEA 75

DEA Cannabis 75

Cannabis Law Report

DECEMBER 18, 2020

SUMMARY: The Drug Enforcement Administration (DEA) is amending its regulations to facilitate the cultivation of … Read More. The post Document – DEA: Controls To Enhance the Cultivation of Marihuana for Research in the United States first appeared on Cannabis Law Report.

DEA 75

DEA Cultivation Law Cannabis 75

Canna Law Blog

AUGUST 24, 2020

In the context of “synthetic marijuana,” which the DEA describes as a “synthetic version of THC,” “synthetic THC” refers to a mixture of plant material sprayed with synthetic psychoactive chemicals.

DEA 83

DEA THC Sativa Hemp 83

MassRoots

NOVEMBER 19, 2018

The Drug Enforcement Administration (DEA) got a slap on the wrist from a federal watchdog agency over its management of a multi-million dollar marijuana eradication program. In a report released on Wednesday, the non-partisan Government Accountability Office (GAO) said the DEA had failed to adequately collect documentation from state and local law enforcement partners that received funds through the federal program.

DEA 63

DEA Programs Collective Environment 63

Canna Law Blog

OCTOBER 23, 2020

Drug Enforcement Administration (“DEA”) to reschedule marijuana. As we all know, the DEA has routinely refused to accept or denied each and every petition, minus one that yielded very specific changes for a synthetic cannabis drug. The DEA’s answering brief is due November 30, 2020.

DEA 61

DEA Policy History Treatment 61

Cannabis Law Report

OCTOBER 12, 2020

District Court to block the DEA from unlawfully criminalizing hemp production The lawsuit also highlights the DEA’s history of … Read More. The detailed complaint asks a U.S.

DEA 70

DEA History Hemp Law 70

Veriheal

DECEMBER 30, 2020

If you answered yes to these two questions, then the DEA might have the job for you. The DEA is seeking a contractor that has the ability to destroy illegal drugs without leaving detectable levels behind. The DEA Says That This isn’t a Job Announcement .

DEA 52

DEA Pharmaceutical Packaging Dispensary 52

Canna Law Blog

JUNE 11, 2020

Today, we focus on some of the high-level requirements of the Drug Enforcement Agency (DEA) on clinics and their personnel. Ketamine is a Schedule III controlled substance, so the Controlled Substances Act (CSA) and federal regulations require that persons who manufacture, distribute, dispense, or otherwise deal in it obtain a DEA registration. In other words, not just anyone can obtain a DEA registration and dispense ketamine.

DEA 48

DEA Retail Medicine Legalization 48

NORML

DECEMBER 16, 2020

Research SCIENCE Congress DEA research Senate University of MississippiFor over five decades, federal regulators have only authorized a single licensee – the University of Mississippi – to cultivate cannabis plants for use in FDA-approved clinical studies.

DEA 207

DEA Cultivation Cannabis 207

Canna Law Blog

OCTOBER 29, 2020

The hemp industry is not the only one that’s pushing back against the Drug Enforcement Administration (DEA)’s hemp Interim Final Rule (the “ Rule ”). If you read this blog, you’ll recall the hemp industry sued the DEA following the release of its Rule in August 2020. Last week, nine members of Congress issued a letter to the DEA’s Acting Administrator, Timothy Shea, to express their concerns regarding the Rule.

DEA 63

DEA Extraction Cannabinoids Agriculture 63

Cannabis Law Report

SEPTEMBER 1, 2020

The hemp has hit the fan…… California’s Bureau of Cannabis Control had refused to give the DEA those documents, arguing in court filings that the … Read More.

DEA 56

DEA Hemp Law Cannabis 56

Canna Law Blog

SEPTEMBER 28, 2020

On August 21, the Drug Enforcement Agency (the “DEA”) released an Interim Final Rule (the “ Rule ”), which, in part, suggests that in-process hemp extract shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3

DEA 81

DEA Agriculture Compliance Compliance 81

Leafly

APRIL 6, 2020

The post DEA loosens rules on prescription CBD drug Epidiolex appeared first on Leafly. Prescription CBD tincture Epidiolex is coming to more patients. Cost: $32,500 per year. Health Politics cannabidiol cbd Epidiolex GW Pharma GW Pharmaceuticals

DEA 66

DEA Tincture Patients Pharmaceutical 66

NORML

DECEMBER 9, 2020

LEGISLATION Research SCIENCE clinical trials DEA House vote research University of Mississippi“These common-sense regulatory changes are necessary and long overdue.

Clinical Trials 207

Clinical Trials Access DEA Legislation 207

Cannabis Law Report

MARCH 24, 2020

Cannabis research in the USA has been held back by the DEA’s stance on the issue, although it has been increasing the amount of cannabis it wants produced for research over the last couple of years. The DEA says the proposed rule will see additional registered growers and more diverse variety of marijuana strains available for research. Currently, the DEA has 37 pending applications to grow marijuana for research.

DEA 67

DEA Extraction Strains Access 67

Cannabis Law Report

APRIL 7, 2020

Well that came out of the blue in the midst of all the other dire news racing through the sector. Cannabis Business Times reports Effective … Read More. Breaking News

DEA 43

DEA Business Cannabis 43

Canna Law Blog

OCTOBER 29, 2020

The hemp industry is not the only one that’s pushing back against the Drug Enforcement Administration (DEA)’s hemp Interim Final Rule (the “ Rule ”). If you read this blog, you’ll recall the hemp industry sued the DEA following the release of its Rule in August 2020.

DEA 54

DEA Extraction Cannabinoids Agriculture 54

Canna Law Blog

SEPTEMBER 1, 2020

Last week the Drug Enforcement Administration (DEA) issued a bad interim hemp rule. North Carolina attorney Rod Kight raised these concerns as well and he and I both spoke to Kyle Jaeger of Marijuana Moment about why we think are concerned about the DEA’s interim hemp rule.

DEA 81

DEA THC Pharmaceutical Oil 81

Canna Law Blog

SEPTEMBER 16, 2020

Unfortunately, the Drug Enforcement Administration (DEA) dropped a surprise interim hemp rule a few weeks ago, which took immediate effect and came as a shock to virtually everyone. The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids.

DEA 82

DEA Hemp THC Cannabinoids 82